Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com
SOURCE FN Media Group, LLC
SOURCE FN Media Group, LLC
SOURCE NXT-ID, Inc.
RELATED LINKS
http://www.nxt-id.com
SOURCE NXT-ID, Inc.
RELATED LINKS
http://www.nxt-id.com
http://www.thewocket.com
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Regulus' expectations regarding future therapeutic and commercial potential of Regulus' business plans, technologies and intellectual property related to microRNA therapeutics being discovered and developed by Regulus. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus' current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs. These and other risks concerning Regulus' programs are described in additional detail in Regulus' SEC filings. All forward-looking statements contained in this press release speak only as of the date on which they were made. Regulus undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.SOURCE Regulus Therapeutics Inc.
RELATED LINKS
http://www.regulusrx.com
SOURCE FST21
RELATED LINKS
http://www.fst21.com
Key Topics Covered:
Executive summary1 Anhui Guangxin Agrochemical
2 Anhui Huaxing Chemical Industry
3 Beijing Nutrichem Biotechnology
4 Hebei Veyong Bio-Chemical
5 Hubei Sanonda
6 Hunan Haili Chemical Industry
7 Jiahua Group
8 Jiangsu Baoling Chemical
9 Jiangsu Changlong Chemicals
10 Jiangsu Changqing Agrochemical
11 Jiangsu Fengshan Group
12 Jiangsu Good Harvest-Weien Agrochemical
13 Jiangsu Huifeng Agrochemical
14 Jiangsu Kwin Group
15 Jiangsu Lanfeng Biochemical
16 Jiangsu Sevencontinent Green Chemical
17 Jiangsu Tianrong Group
18 Jiangsu Yangnong Chemical
19 Lianhe Chemical Technology
20 Lier Chemical
21 Limin Chemical
22 Nanjing Redsun
23 Nantong Jiangshan Agrochemical & Chemicals
24 Hailir Pesticides and Chemicals Group
25 Shandong Binnong Technology
26 Shandong Luba Chemical
27 Shandong Qiaochang Chemical
28 Shandong Weifang Rainbow Chemical
29 Shenyang Sciencreat Chemicals
30 Fuhua Tongda Agro-chemical Technology
31 Zhejiang Jinfanda Biochemical
32 Zhejiang Linghua Industry Company Limited
33 Zhejiang Qianjiang Biochemical
34 Zhejiang Wynca Chemical Industrial Group
35 Zhejiang Yongnong Chem. Ind.
36 Zhongshan Chemical Industries
For more information visit http://www.researchandmarkets.com/research/5vsz5z/company_profiles
SOURCE Research and Markets
RELATED LINKS
http://www.researchandmarkets.com
The following is a summary of the main events in the last few weeks:
MedBox filed its form 10 with the SEC in January and will be an SEC filer, with all the burdens and benefits resulting from that condition, from the middle of March 2014. MedBox issued a special stock dividend to shareholders and which was announced by FINRA on February 03, 2014. MedBox continues to accept customers licensing clinic in Nevada, Illinois, Colorado, Washington and Oregon. Executives of the company clarified its position on the restatement of financial statements that accompanied the registration statement form 10 filed with the SEC as a maturation process in becoming a Cabinet sec."The company undertook a project to bring the functions of accounting at home and during that long process we discovered some errors in accounting since then we have corrected the last financial statements included in the form 10. The point is to hit and be fully transparent with our stakeholders at all times,"said Vincent Mehdizadeh, Chairman at Medbox, Inc."the company has, as part of these corrections, instituted better controls over financial reporting to avoid major corrections. In addition, it is important to point out that revenues in the nine months of the year 2013 had increased during the comparative period of the year before (as corrected) and continue to add qualified people to accelerate our growth in the year 2014. Unfortunately, when you are the most visible company in the space, with a large market capitalization, you become a target."
Executives of the company caution the shareholders of the company while the media has been of great help Medbox as one of the only viable medical marijuana related to public companies, successfully there will always be opponents who publish deceptive and misleading articles about the company and its executives.In addition, company executives said that the company offers support services to the sector of medical marijuana based on the length of an arm. Many times in a State where you are accepting applications for marijuana dispensary licenses, some owners are not leased to nonprofit entities recently formed made up of clients of the company. As a result, in some rare cases, and simply as an absolute benefit to its customers, it was agreed that Medbox lease properties and assign all rights to the applicant, with the permission of the owner.
"We are going the extra mile for our customers and that is evident through our glowing testimonials appear on our web sites," said Dr. Bruce Bedrick, CEO at Medbox, Inc. "it is interesting, with the recent banking policy guidance from the federal Government, now can begin to develop an additional source of income to acquire properties and lease clients of clinic operator." This is one of many sources of revenue that Medbox is developing actively given the current climate and the relaxed posture federal".About Medbox, Inc.:
MedBox is a leader in the development, sales and service of systems of automated dosing and storage, biometrically controlled medicine and merchandise. MedBox has offices in New York, Arizona, Florida, and is headquartered in Los Angeles.MedBox offers its patented systems, software and consulting services to pharmacies, clinics, urgent care centers, clinics of rehabilitation from drugs, hospitals, prison systems, hospice services and medical groups around the world. In addition, through its subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers a medical product industry award-winning vaporizer.
MedBox, Inc. is a company that is listed and traded in the OTC symbol MDBX markets.Forward-looking statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. These statements are based on current beliefs and expectations and are inherently subject to important business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future strategies and decisions that are subject to change. We do not assume any obligation to update any forward-looking statements to reflect events or developments then made a statement with a vision for the future.
For more information about Medbox, please contact us at (800) 762-1452 or visit www.medboxinc.com.Contacts:
Investor relations
Stephen Hart
Hayden IR
+ 1 - 917-658-7878
Hart@HaydenIR.com
SOURCE Medbox, Inc.
RELATED LINKS
http://www.medboxinc.com
While many people want to find out if Garcinia Cambogia can truly help them lose weight, it can be difficult to decide which brand of extract they should purchase. Thanks to the many Garcinia Cambogia reviews—which include information on the Top 5 Extracts that are available in Canada, New Zealand, Australia, the United Kingdom, and other countries—shoppers can rest easy, knowing that they are purchasing a top quality Garcinia Cambogia product.
As an article on the Garcinia Ex website explains, the main ingredient in Garcinia Cambogia supplements is called Hydroxycitric Acid, or HCA. This derivative of citric acid is found in tropical plants. Generally speaking, the article said, Garcinia Cambogia capsules that contain 60 percent HCA are the most beneficial for weight loss.
"The fact is that most Garcinia Cambogia extracts do not come from the same source proven effective in clinical studies," the article noted, adding that in addition, most supplements are not the correct dosage, and do not include enough HCA to make a difference.
"Hundreds of Fly-by-night supplement makers are rushing to create their own product and 'cash-in' on this huge diet. So before you buy, make sure the Garcinia Cambogia extract you choose meets all the criteria."
In addition, while some dietary supplements come with unwanted and unpleasant side effects, since Garcinia Cambogia is made from all natural ingredients, its only known side effect is weight loss.
People who would like to lose weight and want to learn more about Garcinia Cambogia are welcome to visit the newly-updated Garcinia Ex website; there, they can browse through the new information that is part of the site's Garcinia Cambogia launch, as well as what shoppers need to know when they are purchasing the product. Visitors to the site may also click on links that will take them to another website where they can purchase high quality Garcinia Cambogia.
About Garcinia Ex:
Garcinia Ex is a company that researches health supplements that meet specifications within the industry. The researched products are listed on the company's website for the public to learn more about. Garcinia Ex also takes in suggestions from the public for new supplements on the market to conduct research on. For more information, please visit http://garciniaex.com/
Media Contact: Jessie Dean, Garcinia Ex, 480 243-8054, admin@rocketfactor.com News distributed by PR Newswire iReach: https://ireach.prnewswire.comSOURCE Garcinia Ex
Garcinia Ex is a company that researches health supplements that meet specifications within the industry. The researched products are listed on the company's website for the public to learn more about. Garcinia Ex also takes in suggestions from the public for new supplements on the market to conduct research on. For more information, please visit http://garciniaex.com/
Media Contact: Ian Hamilton, Garcinia Ex, 480 243-8054, admin@rocketfactor.com News distributed by PR Newswire iReach: https://ireach.prnewswire.comSOURCE Garcinia Ex
RELATED LINKS
http://garciniaex.com
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.Contact Information:SOURCE FN Media Group, LLC
SOURCE Hoyos Labs
RELATED LINKS
http://www.hoyoslabs.com